PI: Kurt Zatloukal
Focus: One focus is basic research into the molecular disease mechanisms of metabolic diseases of the liver, tumors of the liver and digestive tract, as well as other organs and infectious diseases (COVID-19). We are also involved in the development and standardization of molecular analysis methods and are working on machine learning approaches for the analysis of large image data in digital pathology. As a result, we are involved in the development of several European research infrastructures, such as the biobanking infrastructure (BBMRI-ERIC), the infrastructure for high-security laboratories (ERINHA), and the gene sequencing infrastructure (EASI-Genomics).
Networking: The research work is highly interdisciplinary and is primarily carried out at the European and international level, which is reflected in a strong international network. Overall, there are scientific collaborations with 68 universities and research institutions in 17 countries. In addition, there are several industrial collaborations with national and international companies as well as collaborations with international patient organizations.